Loading...
Curcumin and cancer
Giordano, A Tommonaro, G
Giordano, A
Tommonaro, G
Citations
Altmetric:
Genre
Review
Journal
Journal
Date
2019-10-01
Advisor
Committee member
Group
Department
Permanent link to this record
Collections
Files
Loading...
Curcumin and Cancer.pdf
Adobe PDF, 1.11 MB
Research Projects
Organizational Units
Journal Issue
DOI
10.3390/nu11102376
Abstract
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. Curcumin, a polyphenol extracted from Curcuma longa in 1815, has gained attention from scientists worldwide for its biological activities (e.g., antioxidant, anti-inflammatory, antimicrobial, antiviral), among which its anticancer potential has been the most described and still remains under investigation. The present review focuses on the cell signaling pathways involved in cancer development and proliferation, and which are targeted by curcumin. Curcumin has been reported to modulate growth factors, enzymes, transcription factors, kinase, inflammatory cytokines, and proapoptotic (by upregulation) and antiapoptotic (by downregulation) proteins. This polyphenol compound, alone or combined with other agents, could represent an effective drug for cancer therapy.
Description
Citation
Citation to related work
MDPI AG
Has part
Nutrients
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu